12 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 15 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 15 | Completed 12, Active not recruiting 1, Recruiting 1, Unknown 1 |
Follow Hydroxyurea: new trials by email Literature Review of Hydroxyurea trials Research Report on Hydroxyurea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Hemoglobin F Inducers in Patients With Beta Thalassemia Thalidomide, Hydroxy Urea - Thalassemia | Not applicable | Recruiting | Riphah International University | 240 | 2026-06-20 | 2026-08-06 |
| Primary Prevention of Stroke in Children With Sickle Cell Anaemia in Nigeria in the Community Hydroxyurea - Sickle Cell Disease, Stroke | Not applicable | Unknown | Barau Dikko Teaching Hospital | 217 | 2021-01-06 | 2023-08-01 |
| Hydroxyurea Treatment for Adult Sickle Cell Anemia Patients in Kinshasa Hydroxyurea - Sickle-Cell Anaemia | Not applicable | Completed | University of Kinshasa | 166 | 2017-08-30 | 2023-01-12 |
| Zinc Supplementation in Children With Sickle Cell Disease in Western Kenya Zinc Sulfate Tablets, Standard of Care - Sickle Cell Disease, Zinc Deficiency | Not applicable | Completed | Lucas Otieno Tina, MD MSc | 40 | 2016-05-20 | 2017-09-26 |
| SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia Hydroxyurea, TCD examination - Sickle Cell Anemia | Not applicable | Completed | Children's Hospital Medical Center, Cincinnati | 283 | 2016-03-16 | 2025-08-22 |
| Therapeutic Response Evaluation and Adherence Trial (TREAT) Hydroxyurea - Anemia, Sickle Cell | Not applicable | Active not recruiting | Children's Hospital Medical Center, Cincinnati | 150 | 2014-10-01 | 2025-07-17 |
| Sickle Cell Disease - Stroke Prevention in Nigeria Trial Hydroxyurea - Sickle Cell Anemia, Sickle Cell Disease | Not applicable | Completed | Vanderbilt University Medical Center | 29 | 2013-04-24 | 2020-08-03 |
| Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major Hydroxyurea - Beta-Thalassemia | Not applicable | Completed | University of Washington | 26 | 2006-07-01 | 2012-12-20 |
| Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression Tenofovir, Hydroxyurea - HIV Infections, AIDS | Not applicable | Completed | University of Maryland, Baltimore | 9 | 2003-06-01 | 2021-05-11 |
| Hydroxyurea in Young Children With Sickle Cell Anemia hydroxyurea - Sickle Cell Anemia | Not applicable | Completed | Duke University | 14 | 2002-04-01 | 2007-08-23 |
| Primary Thrombocythaemia 1 Trial Hydroxyurea, Aspirin - Thrombocythemia, Myeloproliferative Disorder | Not applicable | Completed | University of Cambridge | 1398 | 1997-07-01 | 2017-01-18 |
| A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection Hydroxyurea, Nelfinavir mesylate, Stavudine - HIV Infections | Not applicable | Completed | Bristol-Myers Squibb | 1997-05-01 | 2011-04-14 | |
| A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection Hydroxyurea, Nelfinavir mesylate, Stavudine - HIV Infections | Not applicable | Completed | Bristol-Myers Squibb | 1997-05-01 | 2011-04-14 | |
| Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes clotrimazole, hydroxyurea - Sickle Cell Anemia | Not applicable | Completed | Boston Children's Hospital | 20 | 1997-04-01 | 2015-03-25 |
| A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection Indinavir sulfate, Lamivudine/Zidovudine, Ritonavir - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 900 | 2012-06-07 |
Anemia, Sickle Cell (8) · HIV Infections (4) · Stroke (2) · Acquired Immunodeficiency Syndrome (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemorrhage (1) · Infections (1) · Myeloproliferative Disorders (1) · Rare Diseases (1) · Thalassemia (1) · Thrombocytosis (1) · Thrombosis (1) · beta-Thalassemia (1)
Bristol-Myers Squibb (2) · Children's Hospital Medical Center, Cincinnati (2) · Barau Dikko Teaching Hospital (1) · Boston Children's Hospital (1) · Duke University (1) · Lucas Otieno Tina, MD MSc (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Riphah International University (1) · University of Cambridge (1) · University of Kinshasa (1) · University of Maryland, Baltimore (1) · University of Washington (1) · Vanderbilt University Medical Center (1)
United States (7) · Nigeria (2) · Democratic Republic of the Congo (1) · Dominican Republic (1) · Greece (1) · Italy (1) · Pakistan (1) · Puerto Rico (1) · United Kingdom (1)
Anthony R Green, Prof (1) · Carlo Brugnara (1) · Charles Quinn, MD, MS (1) · Claire Harrison, Dr (1) · Courtney D Thornburg, MD mS (1) · Fariha Sardar, MBBS, FCPS (1) · George Stamatoyannopoulos, MD, DrSci (1) · Gregory Robbins (1) · Halima Bello-Manga, MBBS,MPH (1) · Lori Jordan, MD, PhD (1) · Lucas O Tina, MD MSc (1) · Michael R. DeBaun, MD, MPH (1) · Muktar Aliyu, MBBS, MPH, DrPH (1) · Prosper Lukusa Tshilobo (1) · Robert R. Redfield, MD (1)
PMID 14668455, PMID 14668456, PMID 15187476, PMID 16048984, PMID 16103764, PMID 16267764, PMID 16810109, PMID 17662759, PMID 20467286, PMID 24326304, PMID 26615061, PMID 28576754, PMID 30153096, PMID 31106898, PMID 33901188, PMID 34020272, PMID 34227124, PMID 37461538, PMID 38225633, PMID 39820633, PMID 41026975, PMID 42448315, PMID 42577886
R01NS094041 (1), R21NS080639 (1), U01HL066947 (1)